MedTrace Logo

Antihypertensive Therapy in Patients With Comorbidities

NCT04791046 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100000

Last updated 2021-03-11

No results posted yet for this study

Summary

A retrospective analysis

Conditions

  • Adherence to Personalized EBM Antihypertensive Drug Prescriptions for Patients With Hypertension and Comorbidities in Everyday Clinical Practice

Interventions

DRUG

antihypertensive therapy

Personalized evidence-based antihypertensive therapy in patients with comorbidities

Sponsors & Collaborators

  • Center for New Medical Technologies, Novosibirsk, Russia

    collaborator OTHER

  • I.M. Sechenov First Moscow State Medical University

    collaborator OTHER

  • Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health

    collaborator OTHER

  • University of Rochester

    collaborator OTHER

  • Center of Personalized Medicine, Pirogova

    lead OTHER

Principal Investigators

  • Evgeny Pokushalov, Prof. MD PhD · Center for New Medical Technologies, Novosibirsk, Russia

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-01
Primary Completion
2021-03-30
Completion
2021-03-30

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04791046 on ClinicalTrials.gov